Ligustrazine Hydrochloride (CAS No 76494-51-4) is a compound primarily used in the field of biomedical research particularly within pharmacology and cardiovascular studies Originating from the Chinese herb Chuanxiong this molecule is known for its ability to inhibit platelet aggregation and improve microcirculation via mechanisms targeting pathways such as nitric oxide release and calcium channel modulation In vitro activity is typically observed in the nanomolar to low micromolar range indicating its potency Ligustrazine Hydrochloride often serves as an experimental agent in cell models and animal studies to explore therapeutic potentials and screen drug candidates Its typical applications include investigating the treatment of cardiovascular diseases and ischemic conditions Experimental concentrations typically depend on the specific research design allowing for flexibility in dosing to suit various investigative protocols